Interaction between yeast mitochondrial and nuclear genomes: Null alleles of RTG genes affect resistance to the alkaloid lycorine in rho0 petites of Saccharomyces cerevisiae-Reference-Cited by-同舟云学术

Interaction between yeast mitochondrial and nuclear genomes: Null alleles of RTG genes affect resistance to the alkaloid lycorine in rho0 petites of Saccharomyces cerevisiae

Published:2005-07 Issue: Volume:354 Page:9-14
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Del Giudice Luigi,Massardo Domenica Rita,Pontieri Paola,Wolf Klaus

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference29 articles.

1. An ATPase domain common to prokaryotic cell cycle proteins, sugar kinases, actin and hsp70 heat shock proteins;Bork;Proc. Natl. Acad. Sci. U. S. A.,1992

2. Cellular responses to mitochondrial dysfunction: it’s not always downhill;Butow;Cell Death Differ.,2002

3. Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved?;Cavalli;Mutat. Res.,1998

4. Signaling between mitochondria and the nucleus regulates expression of a new d-lactate dehydrogenase;Chelstowska;Yeast,1999

5. Purification of the alkaloid lycorine and simultaneous analysis of ascorbic acid and lycorine by micellar electrokinetic capillary chromatography;Davey;Anal. Biochem.,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saccharomyces: Is a Necessary Organism or a Biological Warrior?;Saccharomyces;2021-07-21

2. Effect of bulb age on alkaloid contents of narcissus pseudonarcissus bulbs;South African Journal of Botany;2021-01

3. Screening of Amaryllidaceae alkaloids in bulbs and tissue cultures of Narcissus papyraceus and four varieties of N. tazetta;Journal of Pharmaceutical and Biomedical Analysis;2019-08

4. Lycorine: A prospective natural lead for anticancer drug discovery;Biomedicine & Pharmacotherapy;2018-11

5. Screening the yeast genome for energetic metabolism pathways involved in a phenotypic response to the anti-cancer agent 3-bromopyruvate;Oncotarget;2016-02-03